This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Tumor necrosis factor receptor 3D structures
From Proteopedia
(Difference between revisions)
| (3 intermediate revisions not shown.) | |||
| Line 20: | Line 20: | ||
**[[4mxv]] – hTNFSF-1 extracellular domain + antibody - human<BR /> | **[[4mxv]] – hTNFSF-1 extracellular domain + antibody - human<BR /> | ||
**[[4mxw]] – hTNFSF-1 extracellular domain + antibody + TNFR-III<BR /> | **[[4mxw]] – hTNFSF-1 extracellular domain + antibody + TNFR-III<BR /> | ||
| + | **[[7kp7]], [[7kp8]] – hTNFR1A + mTNF <BR /> | ||
| + | **[[7kpb]] – hTNFR1A + mTNF + antibody<BR /> | ||
*Tumor necrosis factor receptor superfamily 1B | *Tumor necrosis factor receptor superfamily 1B | ||
**[[3alq]] – hTNFRSF-1B extracellular domain + TNF<br /> | **[[3alq]] – hTNFRSF-1B extracellular domain + TNF<br /> | ||
| + | **[[8hlb]] – hTNFSF-1B extracellular domain + antibody – Cryo EM<BR /> | ||
*Tumor necrosis factor receptor superfamily-4 (OX40L receptor) | *Tumor necrosis factor receptor superfamily-4 (OX40L receptor) | ||
**[[2hev]] – hTNFSF-4 extracellular domain + OX40 ligand<BR /> | **[[2hev]] – hTNFSF-4 extracellular domain + OX40 ligand<BR /> | ||
| - | **[[6ogx]], [[6okm]], [[6okn]] – hTNFSF-4 residues 29-170 + antibody<BR /> | + | **[[6ogx]], [[6okm]], [[6okn]], [[7yk4]], [[8ag1]] – hTNFSF-4 residues 29-170 + antibody<BR /> |
**[[2hew]] – mTNFSF-4 extracellular domain - mouse<BR /> | **[[2hew]] – mTNFSF-4 extracellular domain - mouse<BR /> | ||
**[[2hey]] – mTNFSF-4 extracellular domain + hOX40 ligand<BR /> | **[[2hey]] – mTNFSF-4 extracellular domain + hOX40 ligand<BR /> | ||
| Line 40: | Line 43: | ||
**[[3lkj]], [[5ihl]] – hTNFSF-5 extracellular domain + inhibitor<BR /> | **[[3lkj]], [[5ihl]] – hTNFSF-5 extracellular domain + inhibitor<BR /> | ||
**[[3qd6]] – hTNFRSF-5 extracellular domain + CD40 ligand<br /> | **[[3qd6]] – hTNFRSF-5 extracellular domain + CD40 ligand<br /> | ||
| + | **[[7p3i]] – hTNFRSF-5 extracellular domain + darpin<br /> | ||
| - | *Tumor necrosis factor receptor superfamily-6 (Fas) | + | *Tumor necrosis factor receptor superfamily-6 (Fas, TRAF6) |
**[[3thm]], [[3tje]] – hTNFRSF-6 extracellular domain + antibody<br /> | **[[3thm]], [[3tje]] – hTNFRSF-6 extracellular domain + antibody<br /> | ||
**[[3ezq]] – hTNFRSF-6 Fas DD domain + FADD<br /> | **[[3ezq]] – hTNFRSF-6 Fas DD domain + FADD<br /> | ||
| + | **[[8hz2]] – hTNFRSF-6 N-terminal domain <br /> | ||
**[[3oq9]] – mTNFRSF-6 Fas DD domain + FADD - mouse<br /> | **[[3oq9]] – mTNFRSF-6 Fas DD domain + FADD - mouse<br /> | ||
| Line 54: | Line 59: | ||
**[[3mi8]], [[3k51]] – hTNFRSF-6B extracellular domain + hTNFRSF-15 extracellular domain<br /> | **[[3mi8]], [[3k51]] – hTNFRSF-6B extracellular domain + hTNFRSF-15 extracellular domain<br /> | ||
**[[5l36]] – hTNFRSF-6B extracellular domain + hTNF ligand SF-6 extracellular domain<br /> | **[[5l36]] – hTNFRSF-6B extracellular domain + hTNF ligand SF-6 extracellular domain<br /> | ||
| + | |||
| + | *Tumor necrosis factor receptor superfamily-7 (CD27) | ||
| + | |||
| + | **[[5tlk]], [[7kx0]], [[8ds5]] – hTNFRSF-7 + antibody<br /> | ||
*Tumor necrosis factor receptor superfamily-9 (4-1BBL) | *Tumor necrosis factor receptor superfamily-9 (4-1BBL) | ||
| - | ** | + | **[[6d3n]], [[6mge]] – hTNFSF-9 extracellular domain<BR /> |
**[[2x29]], [[5wiw]] – hTNFSF-9 extracellular domain (mutant)<BR /> | **[[2x29]], [[5wiw]] – hTNFSF-9 extracellular domain (mutant)<BR /> | ||
**[[6mkz]], [[6mgp]] – hTNFRSF-9 residues 24-160 + hTNFLS-9 residues 139-309<BR /> | **[[6mkz]], [[6mgp]] – hTNFRSF-9 residues 24-160 + hTNFLS-9 residues 139-309<BR /> | ||
| - | **[[6cu0]], [[ | + | **[[6cpr]], [[6cu0]] – hTNFRSF-9 residues 24-160 + hTNFLS-9 residues 80-244<BR /> |
| - | **[[ | + | **[[6a3v]] – hTNFRSF-9 residues 24-180 + hTNFLS-9 residues 58-254<BR /> |
| + | **[[6a3w]], [[6mhr]], [[6mi2]], [[7yxu]], [[8gye]] – hTNFRSF-9 residues 24-180 + antibody<BR /> | ||
| + | **[[7d4b]] – hTNFSF-9 residues 25-162 + VHH<BR /> | ||
| + | **[[5wi8]], [[5wjf]] – mTNFSF-9 <BR /> | ||
**[[5wiw]] – mTNFSF-9 (mutant)<BR /> | **[[5wiw]] – mTNFSF-9 (mutant)<BR /> | ||
| Line 70: | Line 82: | ||
*Tumor necrosis factor receptor superfamily-10B (Dr5) | *Tumor necrosis factor receptor superfamily-10B (Dr5) | ||
| - | **[[ | + | **[[1za3]], [[2h9g]], [[4od2]], [[6t3j]], [[8dpx]] – hTNFRSF-10B extracellular domain 58-184 + antibody<br /> |
**[[1d0g]] – hTNFRSF-10B extracellular domain + apoptosis-2 ligand<br /> | **[[1d0g]] – hTNFRSF-10B extracellular domain + apoptosis-2 ligand<br /> | ||
**[[1d4v]] – hTNFRSF-10B extracellular domain + TNF-related apoptosis inducing ligand<br /> | **[[1d4v]] – hTNFRSF-10B extracellular domain + TNF-related apoptosis inducing ligand<br /> | ||
| Line 93: | Line 105: | ||
**[[3urf]] – hTNFRSF-11B extracellular domain + RANKL<br /> | **[[3urf]] – hTNFRSF-11B extracellular domain + RANKL<br /> | ||
**[[4e4d]] – mTNFRSF-11B extracellular domain + RANKL<br /> | **[[4e4d]] – mTNFRSF-11B extracellular domain + RANKL<br /> | ||
| - | |||
| - | *TNFSF-12 superfamily member 12 (TWEAK) | ||
| - | |||
| - | **[[4ht1]] – hTNFSF-12 extracellular domain + antibody<BR /> | ||
*Tumor necrosis factor receptor superfamily-12A (TWEAKR) | *Tumor necrosis factor receptor superfamily-12A (TWEAKR) | ||
| - | **[[ | + | **[[2epq]], [[2kmz]], [[2rpj]] – hTNFRSF-12A cysteine-rich domain – NMR <br /> |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
*Tumor necrosis factor receptor superfamily-13C (BAFF receptor) | *Tumor necrosis factor receptor superfamily-13C (BAFF receptor) | ||
| Line 120: | Line 119: | ||
**[[4fhq]], [[4en0]], [[5t2r]], [[5t2q]] – hTNFRSF-14 extracellular domain <br /> | **[[4fhq]], [[4en0]], [[5t2r]], [[5t2q]] – hTNFRSF-14 extracellular domain <br /> | ||
**[[2aw2]] – hTNFRSF-14 extracellular domain + B and T lymphocyte attenuator <br /> | **[[2aw2]] – hTNFRSF-14 extracellular domain + B and T lymphocyte attenuator <br /> | ||
| - | **[[4rsu]] – hTNFRSF-14 extracellular domain + TNFRSF-14 ligand<br /> | + | **[[4rsu]], [[7msg]] – hTNFRSF-14 extracellular domain + TNFRSF-14 ligand<br /> |
**[[4kg8]] – hTNFSF-14 extracellular domain (mutant)<BR /> | **[[4kg8]] – hTNFSF-14 extracellular domain (mutant)<BR /> | ||
**[[4j6g]] – hTNFSF-14 extracellular domain + DCR3 <BR /> | **[[4j6g]] – hTNFSF-14 extracellular domain + DCR3 <BR /> | ||
| - | **[[ | + | **[[4kgg]], [[4kgq]] – hTNFSF-14 extracellular domain (mutant) + DCR3 <BR /> |
| + | **[[7msj]] – mTNFRSF-14 extracellular domain <br /> | ||
*Tumor necrosis factor receptor superfamily-16 (Low-affinity nerve growth factor receptor; p75NTR; p75 neurotrophin receptor) | *Tumor necrosis factor receptor superfamily-16 (Low-affinity nerve growth factor receptor; p75NTR; p75 neurotrophin receptor) | ||
| Line 136: | Line 136: | ||
**[[2n80]] – hTNFRSF-16 death domain + rho GDP-dissociation inhibitor - NMR<br /> | **[[2n80]] – hTNFRSF-16 death domain + rho GDP-dissociation inhibitor - NMR<br /> | ||
**[[2n83]] – hTNFRSF-16 death domain + receptor interacting Ser/Thr protein kinase - NMR<br /> | **[[2n83]] – hTNFRSF-16 death domain + receptor interacting Ser/Thr protein kinase - NMR<br /> | ||
| + | **[[7csq]] – hTNFRSF-16 death domain + TNFR1-associated death domain protein - NMR<br /> | ||
*Tumor necrosis factor receptor superfamily-17 | *Tumor necrosis factor receptor superfamily-17 | ||
| Line 143: | Line 144: | ||
**[[1xu2]] – hTNFRSF-17 extracellular domain + APRIL <br /> | **[[1xu2]] – hTNFRSF-17 extracellular domain + APRIL <br /> | ||
**[[6j7w]] – hTNFRSF-17 residues 6-44 + antibody heavy chain<br /> | **[[6j7w]] – hTNFRSF-17 residues 6-44 + antibody heavy chain<br /> | ||
| + | **[[8hxr]] – hTNFRSF-17 residues 1-54 + nanobody <br /> | ||
*Tumor necrosis factor receptor superfamily-18 (GITRL) | *Tumor necrosis factor receptor superfamily-18 (GITRL) | ||
| Line 148: | Line 150: | ||
**[[2q1m]], [[3b93]], [[3b94]] – hTNFRSF-18 extracellular domain <br /> | **[[2q1m]], [[3b93]], [[3b94]] – hTNFRSF-18 extracellular domain <br /> | ||
**[[2r30]], [[2r32]] – hTNFRSF-18 extracellular domain (mutant) <br /> | **[[2r30]], [[2r32]] – hTNFRSF-18 extracellular domain (mutant) <br /> | ||
| + | **[[7khd]], [[7law]] – hTNFRSF-18 extracellular domain + TNFLSF18 <br /> | ||
**[[4db5]] – TNFRSF-18 – rabbit <br /> | **[[4db5]] – TNFRSF-18 – rabbit <br /> | ||
**[[4e4s]] – TNFRSF-18 – pika <br /> | **[[4e4s]] – TNFRSF-18 – pika <br /> | ||
**[[4g4f]] – TNFRSF-18 – bushbaby <br /> | **[[4g4f]] – TNFRSF-18 – bushbaby <br /> | ||
**[[3fc0]], [[2qdn]], [[3b9i]] – mTNFRSF-18 <br /> | **[[3fc0]], [[2qdn]], [[3b9i]] – mTNFRSF-18 <br /> | ||
| + | **[[7e57]], [[7khx]] – mTNFRSF-18 extracellular domain + TNFLSF18 <br /> | ||
| + | **[[7rfp]] – mTNFRSF-18 + antibody – Cryo EM<br /> | ||
*Tumor necrosis factor receptor superfamily-21 (Dr6) | *Tumor necrosis factor receptor superfamily-21 (Dr6) | ||
| Line 165: | Line 170: | ||
**[[5ygp]] – hTNFRSF-25 death domain 9 (mutant)<br /> | **[[5ygp]] – hTNFRSF-25 death domain 9 (mutant)<br /> | ||
**[[5yev]] – mTNFRSF-25 death domain<br /> | **[[5yev]] – mTNFRSF-25 death domain<br /> | ||
| + | **[[5zny]] – mMBP/TNFRSF-25 328-409 (mutant)<br /> | ||
| + | |||
| + | *Tumor necrosis factor receptor superfamily EDAR | ||
| + | |||
| + | **[[7x9g]] – hTNFRSF-EDAR + ectodysplasin-A<br /> | ||
}} | }} | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Current revision
3D structures of tumor necrosis factor receptor
Updated on 06-February-2024 - For a general description of the protein see Tumor necrosis factor receptor
